Back
29
Day Range
$32.08
$33.81
52-Week Range
$22.61
$50.71
Volume
1,235,624
50D / 200D Avg
$37.13
/
$34.68
Prev Close
$31.84
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 40.2 | 0.4 |
| P/B | 2.0 | 2.9 |
| ROE % | 5.3 | 3.8 |
| Net Margin % | 12.8 | 3.9 |
| Rev Growth 5Y % | 23.9 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 23.89% annually over 5 years — strong growth
Earnings grew 174.89% over the past year
Debt/Equity of 0.03 — conservative balance sheet
Generating 126.63M in free cash flow
P/E of 40.16 — premium valuation
PEG of 0.31 suggests growth is underpriced
Growth
Revenue Growth (5Y)
23.89%
Revenue (1Y)16.01%
Earnings (1Y)174.89%
FCF Growth (3Y)92.25%
Quality
Return on Equity
5.34%
ROIC4.12%
Net Margin12.83%
Op. Margin14.34%
Safety
Debt / Equity
0.03
Current Ratio8.15
Interest Coverage0.00
Valuation
P/E Ratio
40.16
P/B Ratio2.04
EV/EBITDA31.59
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.01% | Revenue Growth (3Y) | 19.68% |
| Earnings Growth (1Y) | 174.89% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23.89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 517.15M | Net Income (TTM) | 66.35M |
| ROE | 5.34% | ROA | 4.72% |
| Gross Margin | 69.62% | Operating Margin | 14.34% |
| Net Margin | 12.83% | Free Cash Flow (TTM) | 126.63M |
| ROIC | 4.12% | FCF Growth (3Y) | 92.25% |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 8.15 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 40.16 | P/B Ratio | 2.04 |
| P/S Ratio | 5.15 | PEG Ratio | 0.31 |
| EV/EBITDA | 31.59 | Dividend Yield | 0.00% |
| Market Cap | 2.67B | Enterprise Value | 2.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 517.15M | 445.76M | 361.05M | 296.54M | 219.51M |
| Net Income | 66.35M | 24.14M | -74.40M | -36.56M | -75.56M |
| EPS (Diluted) | 0.82 | 0.31 | -1.02 | -0.51 | -1.11 |
| Gross Profit | 360.05M | 298.15M | 248.15M | 194.95M | 145.11M |
| Operating Income | 74.15M | 16.14M | -85.80M | -41.08M | -81.90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.41B | 1.30B | 1.11B | 1.16B | 1.19B |
| Total Liabilities | 96.44M | 124.07M | 70.80M | 81.22M | 91.31M |
| Shareholders' Equity | 1.31B | 1.18B | 1.04B | 1.08B | 1.10B |
| Total Debt | 39.65M | 50.74M | 12.63M | 14.72M | 18.85M |
| Cash & Equivalents | 362.58M | 239.09M | 216.45M | 154.25M | 173.20M |
| Current Assets | 488.38M | 372.27M | 285.62M | 248.64M | 243.10M |
| Current Liabilities | 59.94M | 78.63M | 61.24M | 62.61M | 64.15M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#829 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026